Mumbai, October 20 (Udaipur Kiran): Shares of Alembic Pharmaceuticals Limited gained over 1% in Monday’s trade after the company received final approval from the U.S. Food and Drug Administration (USFDA) for its Triamcinolone Acetonide Injectable Suspension USP. The stock was trading at Rs. 947.55, up Rs. 10.05 or 1.07% from its previous close of Rs. … Read more
Alembic Pharmaceuticals is currently trading at Rs. 873.20, up by 5.75 points or 0.66% from its previous closing of Rs. 867.45 on the BSE. The scrip opened at Rs. 883.25 and has touched a high and low of Rs. 894.00 and Rs. 871.00 respectively. So far 3239 shares were traded on the counter. The BSE … Read more
Alembic Pharmaceuticals is currently trading at Rs. 1013.55, up by 8.70 points or 0.87% from its previous closing of Rs. 1004.85 on the BSE. The scrip opened at Rs. 1008.95 and has touched a high and low of Rs. 1035.00 and Rs. 1003.80 respectively. So far 3128 shares were traded on the counter. The BSE … Read more
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide Capsules, 25 mg and 50 mg. he approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cyclophosphamide Capsules, 25 mg and 50 mg, of Hikma Pharmaceuticals USA Inc. Cyclophosphamide … Read more
Alembic Pharmaceuticals is currently trading at Rs. 661.55, up by 49.35 points or 8.06% from its previous closing of Rs. 612.20 on the BSE. The scrip opened at Rs. 608.70 and has touched a high and low of Rs. 675.00 and Rs. 603.55 respectively. So far 143890 shares were traded on the counter. The BSE … Read more
Alembic Pharmaceuticals is currently trading at Rs. 520.00, up by 9.65 points or 1.89% from its previous closing of Rs. 510.35 on the BSE. The scrip opened at Rs. 520.00 and has touched a high and low of Rs. 525.80 and Rs. 517.15 respectively. The BSE group ‘A’ stock of face value Rs. 2 has … Read more
